• Mashup Score: 0

    The effect of coronavirus disease 2019 (COVID-19) on liver transplantation programmes and recipients is still not completely understood but overall involves the risk of donor-derived transmission, the reliability of diagnostic tests, health-care resource utilization and the effect of immunosuppression. This Comment reviews the effect of COVID-19 on liver transplantation and summarizes…

    Tweet Tweets with this article
    • Marina Berenguer on #COVID19 & liver #transplantation at #ILC2020, highlighting approach for patients undergoing transplantation during the pandemic. Further reading in her @NatRevGastroHep Comment https://t.co/Ik7zvPhADm [KR] https://t.co/Se2Ty5Gffn

  • Mashup Score: 0
    COVID-Hep registry - 4 year(s) ago

    The advent and pandemic spread of the novel coronavirus SARS-CoV2, and its associated disease state COVID-19, is a major and developing international public health emergency. The spectrum of disease and factors that influence the disease course are incompletely defined. We have established this universal and collaborative registry project to collect data on…

    Tweet Tweets with this article
    • Up next at #ILC2020 Thomas Marjot on SARS-CoV-2 infection in patients with chronic liver disease & an update on the @CovidHep https://t.co/4TYWBRlaMz & @SecureCirrhosis https://t.co/ErNg85gMHm registry data, working in collaboration & operating since 25th March

  • Mashup Score: 0

    In this exclusive video, Thomas Berg, MD, head of the section of hepatology at The University of Leipzig, discusses data presented at The Digital International Liver Congress on the role of non-alcoholic fatty liver disease in COVID-19 mortality risk.

    Tweet Tweets with this article
    • We talked to Thomas Berg, MD, head of the section of hepatology at The University of Leipzig, about the role of non-alcoholic fatty liver disease in #COVID19 mortality risk. #ILC2020 https://t.co/iVcRddRQaj